AzTrials
AzTrials

Edentulous JawNCT07821905

Accuracy of Complete-arch Implant Scans Obtained Using T-Marker

A study testing Smartphone and Tablet in people with Edentulous Jaw, run by Menoufia University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This randomized crossover clinical study will evaluate and compare the accuracy and effective scanning time of complete-arch implant scans obtained using the (TruAbutment,Marker) T-Marker photogrammetry application operated on a smartphone and a tablet. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Edentulous Jaw
What is being tested?
Smartphone and Tablet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
1 Aug 2026to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Adults aged 40-60
  • Completely edentulous maxillary arch.
  • Four well-integrated dental implants connected to multiunit abutments.
  • Implants positioned in the right and left canine and molar regions.
  • Presence of a screw-retained interim implant-supported prosthesis or need for definitive implant-supported prosthetic rehabilitation.
  • Willingness to provide written informed consent.

Who cannot join

  • Fewer than four implants.
  • Implants placed in the mandibular arch.
  • Failed implants.
  • Active peri-implant infection or suppuration

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Mohammed Elsawy

    Shibīn al Kawm, Menoufia, 2266166

Other trials in Egypt

About this study

Official title: Accuracy of Complete-arch Implant Scans Obtained Using (TruAbutment,Marker)T-Marker Obtained With a Mobile Phone and Tablet: A Randomized Crossover Clinical Study

This randomized crossover clinical study will evaluate and compare the accuracy and effective scanning time of complete-arch implant scans obtained using the (TruAbutment,Marker) T-Marker photogrammetry application operated on a smartphone and a tablet. Twenty-four patients with completely edentulous arches rehabilitated with four well-integrated implants connected to multiunit abutments will undergo both digital impression protocols in a randomized sequence. A verified conventional implant cast will serve as the reference standard. Linear and angular deviations between the implant positions obtained using each digital protocol and the reference model will be evaluated using three-dimensional analysis software. Effective scanning time required for implant coordinate acquisition and registration will also be recorded. The study will determine whether the use of T-Marker with a smartphone provides accuracy and scanning efficiency comparable to its use with a tablet.

Read the detailed description

Complete-arch implant scanning is challenging because of the large interimplant distances and the limited availability of stable anatomical landmarks, which may result in cumulative image-stitching errors. Photogrammetry-based workflows have been introduced to improve the accuracy of implant position recording. T-Marker is a photogrammetry application that uses external optical markers and image-acquisition protocols to determine implant positions.

This randomized crossover clinical study will compare two T-Marker acquisition devices: a smartphone and a tablet. Each participant will undergo both digital impression protocols, with the order of the protocols randomized to minimize potential order and operator-learning effects.

A verified conventional splinted implant impression will be used to fabricate a master cast, which will be digitized using a calibrated laboratory scanner to generate the reference dataset. T-Marker optical markers will then be attached to the multiunit abutments, and complete-arch implant position data will be acquired using either an iPhone 15 Pro Max or a tablet. The resulting digital datasets will be compared with the reference dataset using three-dimensional analysis software.

Linear and angular deviations will be evaluated to determine the trueness of the implant position measurements. Effective scanning time, defined as the time required to acquire and register all implant positions using the photogrammetric acquisition mode, will also be recorded. Surface and soft-tissue scanning, STL export, and data-merging procedures will not be included in the scanning-time measurement.

Conditions
Edentulous Jaw
Being tested
Smartphone, Tablet
Medical subject headings
Jaw, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SmartphoneDevice

    Also called T-Marker Photogrammetry With Smartphone

    Complete-arch implant positions are captured using T-Marker optical markers attached to the multiunit abutments and a smartphone-based photogrammetry workflow. An iPhone 15 Pro Max running the T-Marker application is used to acquire and register the implant positions.

  • TabletDevice

    Complete-arch implant positions are captured using T-Marker optical markers attached to the multiunit abutments and a tablet running the T-Marker application. The system captures and registers the three-dimensional positions of the four implants.

Study groups in NCT07821905
Study groupRoleWhat they receive
T-Marker With SmartphoneExperimentalParticipants undergo complete-arch implant scanning using T-Marker optical markers attached to the multiunit abutments and a smartphone-based photogrammetry workflow.
Receives: Device: Smartphone; Device: Tablet
T-Marker With TabletExperimentalParticipants undergo complete-arch implant scanning using T-Marker optical markers attached to the multiunit abutments and a Tablet-based photogrammetry workflow.
Receives: Device: Smartphone; Device: Tablet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Angular deviation of complete-arch implant scans

    Angular deviation of the implant positions obtained using T-Marker photogrammetry with a smartphone or tablet, compared with the reference implant positions obtained from the verified conventional splinted impression. Angular deviation will be measured in degrees using three-dimensional inspection software.

    Measured: Immediately after each digital impression procedure

Secondary outcomes (1)
  1. Linear deviation of complete-arch implant scans

    Linear deviation of the implant positions obtained using T-Marker photogrammetry with a smartphone or tablet, compared with the reference implant positions obtained from the verified conventional splinted impression. Linear deviation will be measured in micrometers using three-dimensional inspection software.

    Measured: Immediately after each digital impression procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2026
  2. Study start1 Aug 2026
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
Each participant will undergo both digital impression protocols using the T-Marker application, with implant position acquisition performed using a smartphone and a tablet. The order of the two protocols will be randomized using a computer-generated randomization sequence.
Masking
None (open label)
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07821905
Sponsor's protocol ID
ADMNF-0426
Status last verified
Sep 2026
First submitted
8 Sep 2026
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Up on reasonable request from the corresponding author.

Questions about this trial

What is this clinical trial studying?

A study testing Smartphone and Tablet in people with Edentulous Jaw, run by Menoufia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Angular deviation of complete-arch implant scans (time frame: Immediately after each digital impression procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in